Increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis.

Increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis.

Item
http://www.wikidata.org/entity/Q30484210
A pilot study to examine the correlation between cognition and blood biomarkers in a Singapore Chinese male cohort with type 2 diabetes mellitusCarotid atherosclerosis and 10-year changes in cognitive function.The prevalence of age-related macular degeneration and associated risk factorsThe ten-year incidence of tinnitus among older adultsThe effects of cholesterol on learning and memory.Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's diseaseOlfactory impairment in older adults: five-year incidence and risk factorsAssociation of Biomarkers for Inflammation, Endothelial Dysfunction and Oxidative Stress with Cognitive Impairment. The Epidemiology of Hearing Loss Study (EHLS).Lipid lowering agents, cognitive decline, and dementia: the three-city study.Statins and cognitive function: an updated review.Nonlinear associations between plasma cholesterol levels and neuropsychological function.On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks.Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses.The association between macronutrient intake and cognition in individuals aged under 65 in China: a cross-sectional study.
P2860

Increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis.

Item
http://www.wikidata.org/entity/Q30484210
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Increased atherogenic lipoprot ...... d subclinical atherosclerosis.
@ast
Increased atherogenic lipoprot ...... d subclinical atherosclerosis.
@en
type
label
Increased atherogenic lipoprot ...... d subclinical atherosclerosis.
@ast
Increased atherogenic lipoprot ...... d subclinical atherosclerosis.
@en
prefLabel
Increased atherogenic lipoprot ...... d subclinical atherosclerosis.
@ast
Increased atherogenic lipoprot ...... d subclinical atherosclerosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Increased atherogenic lipoprot ...... d subclinical atherosclerosis.
@en
P2093
P2860
P304
P31
P356
10.1097/WAD.0B013E3181850188
P407
P433
P478
P50
P577
P698
P921
P932